Hydatid disease: vaccinology and development of the EG95 recombinant vaccine

References

• Jenkins DJ, Macpherson CN. Transmission ecology of Echinococcus in wildlife in Australia and Africa. Parasitology127(Suppl.), S63–S72 (2003).
   Google Scholar
• Eckert J, Gemmell MA, Meslin F, Pawlowski ZS. WHO/OIE manual on echinococcosis in humans and animals: a public health problem of global concern. World Health Organization, Geneva (2001).
   Google Scholar
• Craig PS, Deshan L, Zhaoxun D. Hydatid disease in China. Parasitol.Today7, 46–50 (1991).
   PubMedGoogle Scholar
• Eckert J, Conraths FJ, Tackmann K. Echinococcosis: an emerging or re-emerging zoonosis? Int. J. Parasitol.30, 1283–1294 (2000).
   PubMed Web of Science ®Google Scholar
• Vuitton DA, Zhou H, Bresson-Hadni S et al. Epidemiology of alveolar echinococcosis with particular reference to China and Europe. Parasitology127(Suppl.), S87–S107 (2003).
   Web of Science ®Google Scholar
• Craig PS, Giraudoux P, Shi D et al. An epidemiological and ecological study of human alveolar echinococcosis transmission in south Gansu, China. Acta Trop.77, 167–77 (2000).
   PubMed Web of Science ®Google Scholar
• Schantz PM, Wang H, Qiu J et al. Echinococcosis on the Tibetan Plateau: prevalence and risk factors for cystic and alveolar echinococcosis in Tibetan populations in Qinghai Province, China. Parasitology127(Suppl.), S109–S120 (2003).
   Google Scholar
• Gemmell MA, Lawson JR, Roberts MG. Population dynamics in echinococcosis and cysticercosis: biological parameters of Echinococcus granulosus in dogs and sheep. Parasitology92, 599–620 (1986).
   PubMed Web of Science ®Google Scholar
• Movsesijan M, Sokolic A, Mladenovic Z. Studies on the immunological potentiality of irradiated Echinococcus granulosus forms: immunization experiments in dogs. Br. Vet. J.124, 425–432 (1968).
   PubMedGoogle Scholar
• Herd RP. Resistance of dogs to Echinococcus granulosus. Int. J. Parasitol.7, 135–138 (1977).
   PubMedGoogle Scholar
• Herd RP, Chappel RJ, Biddell D. Immunization of dogs against Echinococcus granulosus using worm secretory antigens. Int. J. Parasitol.5, 395–399 (1975).
   PubMedGoogle Scholar
• Gemmell MA. Natural and acquired immunity factors interfering with development during the rapid growth phase of Echinococcus granulosus in dogs. Immunology5, 495–503 (1962).
   Google Scholar
• Barriga OO, Al-Khalidi NW. Humoral immunity in the prepatent primary infection of dogs with Echinococcus granulosus. Vet. Immunol. Immunopathol.11, 375–89 (1986).
   PubMedGoogle Scholar
• Al-Khalidi NW, Barriga OO. Cell-mediated immunity in the prepatent primary infection of dogs with Echinococcus granulosus. Vet. Immunol. Immunopathol.11, 73–82 (1986).
   PubMedGoogle Scholar
• Deplazes P, Thompson RC, Constantine CC, Penhale WJ. Primary infection of dogs with Echinococcus granulosus: systemic and local (Peyer’s patches) immune responses. Vet. Immunol. Immunopathol.40, 171–184 (1994).
   PubMedGoogle Scholar
• Moreno M, Benavidez U, Carol H et al. Local and systemic immune responses to Echinococcus granulosus in experimentally infected dogs. Vet. Parasitol.119, 37–50 (2004).
   PubMedGoogle Scholar
• Carol H, Nieto A. A mucosal IgA response, but no systemic antibody response, is evoked by intranasal immunisation of dogs with Echinococcus granulosus surface antigens iscoms. Vet. Immunol. Immunopathol.65, 29–41 (1998).
   PubMed Web of Science ®Google Scholar
• Esteves A, Portillo V, Ehrlich R. Genomic structure and expression of a gene coding for a new fatty acid binding protein from Echinococcus granulosus. Biochim. Biophys. Acta1631, 26–34 (2003).
   PubMedGoogle Scholar
• Esteves A, Senorale M, Ehrlich R. A tropomyosin gene is differentially expressed in the larval stage of Echinococcus granulosus.Parasitol Res.89, 501–502 (2003).
   Google Scholar
• Saboulard D, Lahmar S, Petavy AF, Bosquet G. The Echinococcus granulosus antigen EgA31: localization during development and immunogenic properties. Parasite Immunol.25, 489–501 (2003).
   PubMedGoogle Scholar
• Miller HM. Immunity in the white rat to super infestation with Cysticercus fasciolaris. Proc. Soc. Exp. Biol.28, 467–468 (1931).
   Google Scholar
• Kerr KB. Immunity against a cestode parasite – Cysticercus pisiformis. Am. J. Hyg.22, 169–182 (1935).
   Google Scholar
• Penfold WG, Penfold HB. Cysticercosis bovis and its prevention. J. Helminthology15, 37–40 (1937).
   Google Scholar
• Gemmell MA, Johnstone PD. Factors regulating tapeworm populations: estimations of the duration of acquired immunity by sheep to Taenia hydatigena. Res.Vet. Sci.30, 53–56 (1981).
   PubMedGoogle Scholar
• Sweatman GK, Williams RJ, Moriarty KM, Henshall TC. On acquired immunity to Echinococcus granulosus in sheep. Res.Vet. Sci.4, 187–198 (1963).
   Google Scholar
• Dempster RP, Harrison GBL, Berridge MV. Maternal transfer of protection from Echinococcus granulosus infection in sheep. Res. Vet. Sci.58, 197–202 (1995).
   PubMedGoogle Scholar
• Gemmell MA. Immunological responses of the mammalian host against tapeworm infections. IV. Species specificity of hexacanth embryos in protecting sheep against Echinococcus granulosus. Immunology11, 325–35 (1966).
   PubMed Web of Science ®Google Scholar
• Heath DD, Parmeter SN, Osborn PJ, Lawrence SB. Resistance to Echinococcus granulosus infection in lambs. J. Parasitol.67, 797–799 (1981).
   PubMedGoogle Scholar
• Osborn PJ, Heath DD. Immunisation of lambs against Echinococcus granulosus using antigens obtained by incubation of oncospheres in vitro. Res. Vet. Sci.33, 132–133 (1982).
   PubMedGoogle Scholar
• Heath DD, Lawrence SB. Antigenic polypeptides of Echinococcus granulosus oncospheres and definition of protective molecules. Parasite Immunol.18, 347–357 (1996).
   PubMedGoogle Scholar
• Johnson KS, Harrison GB, Lightowlers MW et al. Vaccination against ovine cysticercosis using a defined recombinant antigen. Nature338, 585–587 (1989).
   PubMed Web of Science ®Google Scholar
• Lightowlers MW, Lawrence SB, Gauci CG et al. Vaccination against hydatidosis using a defined recombinant antigen. Parasite Immunol.18, 457–62 (1996).
   PubMed Web of Science ®Google Scholar
• Smith DB, Johnson KS. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene67, 31–40 (1988).
   PubMed Web of Science ®Google Scholar
• Heath DD, Jensen O, Lightowlers MW. Progress in control of hydatidosis using vaccination-a review of formulation and delivery of the vaccine and recommendations for practical use in control programmes. Acta Trop.85, 133–143 (2003).
   PubMedGoogle Scholar
• Lightowlers MW, Flisser A, Gauci CG et al. Vaccination against cysticercosis and hydatid disease. Parasitol. Today16, 191–196 (2000).
   PubMedGoogle Scholar
• Lightowlers MW, Jensen O, Fernandez E et al. Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep. Int. J. Parasitol.29, 531–534 (1999).
   PubMedGoogle Scholar
• Gauci C, Merli M, Muller V et al. Molecular cloning of a vaccine antigen against infection with the larval stage of Echinococcus multilocularis. Infect. Immun.70, 3969–3972 (2002).
   PubMed Web of Science ®Google Scholar
• Merckelbach A, Wager M, Lucius R. Analysis of cDNAs coding for immunologically dominant antigens from an oncosphere-specific cDNA library of Echinococcus multilocularis. Parasitol. Res.90, 493–501 (2003).
   PubMedGoogle Scholar
• Muller-Schollenberger V, Beyer W, Schnitzler P et al. Immunization with Salmonella typhimurium-delivered glyceraldehyde-3-phosphate dehydrogenase protects mice against challenge infection with Echinococcus multilocularis eggs. Int. J. Parasitol.31, 1441–1449 (2001).
   PubMedGoogle Scholar
• Siles-Lucas M, Merli M, Mackenstedt U, Gottstein B. The Echinococcus multilocularis 14-3-3 protein protects mice against primary but not secondary alveolar echinococcosis. Vaccine21, 431–439 (2003).
   PubMedGoogle Scholar
• Thompson RC, McManus DP. Towards a taxonomic revision of the genus Echinococcus. Trends Parasitol.18, 452–457 (2002).
   PubMed Web of Science ®Google Scholar
• Chow C, Gauci CG, Cowman AF, Lightowlers MW. A gene family expressing a host-protective antigen of Echinococcus granulosus. Mol. Biochem. Parasitol.118, 83–88 (2001).
   PubMedGoogle Scholar
• Zhang W, Li J, You H et al. Short report: Echinococcus granulosus from Xinjiang, PR China: cDNAS encoding the EG95 vaccine antigen are expressed in different lifecycle stages and are conserved in the oncosphere. Am. J. Trop. Med. Hyg.68, 40–43 (2003).
   PubMedGoogle Scholar
• Gemmell MA, Soulsby EJ. The development of acquired immunity to tapeworms and progress towards active immunization, with special reference to Echinococcus spp. Bull.World Health Org.39, 45–55 (1968).
   PubMedGoogle Scholar
• Chow C, Gauci CG, Cowman AF, Lightowlers MW. Echinococcus granulosus: oncosphere-specific transcription of genes encoding a host-protective antigen. Exp. Parasitol.106, 183–186 (2004).
   PubMedGoogle Scholar
• Heath DD, Smyth JD. In vitro cultivation of Echinococcus granulosus, Taeniahydatigena, T. ovis, T.pisiformis and T. serialis from oncosphere to cystic larva. Parasitology61, 329–343 (1970).
   PubMed Web of Science ®Google Scholar
• Heath DD, Lawrence SB. Echinococcus granulosus: development in vitro from oncosphere to immature hydatid cyst. Parasitology73, 417–423 (1976).
   PubMed Web of Science ®Google Scholar
• Heath DD, Lawrence SB. Echinococcus granulosus cysts: early development in vitro in the presence of serum from infected sheep. Int. J. Parasitol.11, 261–266 (1981).
   PubMedGoogle Scholar
• Woollard DJ, Gauci CG, Lightowlers MW. Synthetic peptides induce antibody against a host-protective antigen of Echinococcusgranulosus. Vaccine18, 785–794 (2000).
   Google Scholar
• Woollard DJ, Gauci CG, Heath DD, Lightowlers MW. Epitope specificities and antibody responses to the EG95 hydatid vaccine. Parasite Immunol.20, 535–540 (1998).
   PubMedGoogle Scholar
• Woollard DJ, Heath DD, Lightowlers MW. Assessment of protective immune responses against hydatid disease in sheep by immunization with synthetic peptide antigens. Parasitology121(2), 145–153 (2000).
   PubMedGoogle Scholar
• Woollard DJ, Gauci CG, Heath DD, Lightowlers MW. Protection against hydatid disease induced with the EG95 vaccine is associated with conformational epitopes. Vaccine19, 498–507 (2001).
   Google Scholar
• Lightowlers MW, Colebrook AL, Gauci CG et al. Vaccination against cestode parasites: antihelminth vaccines that work and why. Vet. Parasitol.115, 83–123 (2003).
   PubMed Web of Science ®Google Scholar
• Vercruysse J, Knox DP, Schetters TP, Willadsen P. Veterinary parasitic vaccines: pitfalls and future directions. Trends Parasitol.20, 488–492 (2004).
   PubMedGoogle Scholar
• Dalton JP, Brindley PJ, Knox DP et al. Helminth vaccines: from mining genomic information for vaccine targets to systems used for protein expression. Int. J. Parasitol.33, 621–640 (2003).
   PubMedGoogle Scholar
• Scheerlinck JP, Casey G, McWaters P et al. The immune response to a DNA vaccine can be modulated by codelivery of cytokine genes using a DNA prime–protein boost strategy. Vaccine19, 4053–4060 (2001).
   PubMed Web of Science ®Google Scholar
• Marsland BJ, Tisdall DJ, Heath DD, Mercer AA. Construction of a recombinant orf virus that expresses an Echinococcus granulosus vaccine antigen from a novel genomic insertion site. Arch. Virol.148, 555–562 (2003).
   PubMedGoogle Scholar